Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - INTEREST INCOME & EXPENSE
Interest Income & Expense UTHR - United Therapeutics Corporation
59.3 M
LAST VALUE
78.55%
2 YEAR CAGR
33.66%
5 YEAR CAGR
12.63%
10 YEAR CAGR